Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Body weight-based AOD-9604 dosing protocols Body composition significantly impacts peptide distribution and effectiveness
In our immunofluorescence experiment with insulin labeled cell and glucagon labeled cell, we found that after berberine treatment, the ratio of cell to cell increased
The medication is usually introduced gradually, so it may take time to reach an effective dose
Nothing was shifting during shipping
Technical Specifications Compounds Included: GHK-Cu, BPC-157, TB-500 Total Peptide Content: 70 mg (50mg GHK-Cu, 10mg BPC-157, 10mg TB-500) Format: Lyophilized peptide blend Purity: 9899% (COA included) Appearance: Blue-tinted and white lyophilized peptide mixture Category: Research peptide reagent Intended Use Approved for: Laboratory experimentation In-vitro biochemical assays Multi-pathway mechanistic studies Preclinical, non-human research modeling Advanced peptide interaction analysis Academic or institutional research Not approved for: Human or veterinary consumption Injection, ingestion, inhalation, or topical application Cosmetic, dermatological, or therapeutic purposes Any clinical or medical application This product is not approved by FDA, Health Canada, or similar regulatory bodies for human use
Padded clothing for comfort
